An Integrated Human Mammary Epithelial Cell Culture System for Studying Carcinogenesis and Aging

[1]  M. Stampfer,et al.  Processing of Human Reduction Mammoplasty and Mastectomy Tissues for Cell Culture , 2013, Journal of visualized experiments : JoVE.

[2]  A. Borowsky,et al.  Accumulation of multipotent progenitors with a basal differentiation bias during aging of human mammary epithelia. , 2012, Cancer research.

[3]  A. Børresen-Dale,et al.  The Life History of 21 Breast Cancers , 2012, Cell.

[4]  A. Børresen-Dale,et al.  Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.

[5]  A. Børresen-Dale,et al.  The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.

[6]  F. D. D. Fagagna,et al.  Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation , 2012, Nature Cell Biology.

[7]  P. Lansdorp,et al.  Collapse of Telomere Homeostasis in Hematopoietic Cells Caused by Heterozygous Mutations in Telomerase Genes , 2012, PLoS genetics.

[8]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[9]  Irmtraud M. Meyer,et al.  The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.

[10]  L. Tusell,et al.  Progressive Telomere Dysfunction Causes Cytokinesis Failure and Leads to the Accumulation of Polyploid Cells , 2012, PLoS genetics.

[11]  J. Brugge,et al.  Outgrowth of Single Oncogene-expressing Cells from Suppressive Epithelial Environments , 2012, Nature.

[12]  M. Stampfer,et al.  Oncogenes induce senescence with incomplete growth arrest and suppress the DNA damage response in immortalized cells , 2011, Aging cell.

[13]  M. Pagel,et al.  Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination , 2011, Aging cell.

[14]  C. Perou,et al.  Defining the cellular precursors to human breast cancer , 2011, Proceedings of the National Academy of Sciences.

[15]  Martha R. Stampfer,et al.  Epigenetic regulation of normal human mammary cell type-specific miRNAs. , 2011, Genome research.

[16]  M. Jackson,et al.  TGF-β signaling engages an ATM-CHK2-p53–independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells , 2011, Proceedings of the National Academy of Sciences.

[17]  M. Bissell,et al.  Self-organization is a dynamic and lineage-intrinsic property of mammary epithelial cells , 2011, Proceedings of the National Academy of Sciences.

[18]  K. Struhl,et al.  Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion , 2011, Proceedings of the National Academy of Sciences.

[19]  Virginia Espina,et al.  What is the malignant nature of human ductal carcinoma in situ? , 2011, Nature Reviews Cancer.

[20]  L. Sealy,et al.  Regulation of C/EBPbeta1 by Ras in mammary epithelial cells and the role of C/EBPbeta1 in oncogene-induced senescence , 2010, Oncogene.

[21]  D. Carrasco,et al.  PIK3CA mutations in in situ and invasive breast carcinomas. , 2010, Cancer research.

[22]  Lior Pachter,et al.  Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer , 2010, Molecular Cancer Research.

[23]  D. Beach,et al.  Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21Waf1/Cip1 , 2010, Oncogene.

[24]  Bahram Parvin,et al.  Molecular Predictors of 3D Morphogenesis by Breast Cancer Cell Lines in 3D Culture , 2010, PLoS Comput. Biol..

[25]  T. Sørlie,et al.  Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer , 2010, Breast Cancer Research.

[26]  P. Argani,et al.  The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression , 2009, Modern Pathology.

[27]  Heidi S Feiler,et al.  Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells. , 2009, Cancer research.

[28]  S. Fox,et al.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers , 2009, Nature Medicine.

[29]  D. Shore,et al.  Telomere length regulation: coupling DNA end processing to feedback regulation of telomerase , 2009, The EMBO journal.

[30]  M. Stampfer,et al.  Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization. , 2009, Cancer research.

[31]  Taylor Jensen,et al.  Agglomerative epigenetic aberrations are a common event in human breast cancer. , 2008, Cancer research.

[32]  Jiri Bartek,et al.  An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.

[33]  M. Stampfer.  Cholera toxin stimulation of human mammary epithelial cells in culture , 1982, In Vitro.

[34]  T. Tlsty,et al.  Inactivation of p53 Function in Cultured Human Mammary Epithelial Cells Turns the Telomere-Length Dependent Senescence Barrier from Agonescence into Crisis , 2007, Cell cycle.

[35]  Charles M Perou,et al.  EGFR associated expression profiles vary with breast tumor subtype , 2007, BMC Genomics.

[36]  Genee Y. Lee,et al.  The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.

[37]  K. Siziopikou,et al.  The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies. , 2007, Breast.

[38]  M. Hosobuchi,et al.  Effects of transforming growth factor β on growth of human mammary epithelial cells in culture , 1989, In Vitro Cellular & Developmental Biology.

[39]  M. Stampfer,et al.  Growth of normal human mammary cells in culture , 1980, In Vitro.

[40]  M. Stampfer,et al.  Solar flair. , 2003, Molecular Cancer.

[41]  Taylor Jensen,et al.  Epigenetic inactivation of the HOXA gene cluster in breast cancer. , 2006, Cancer research.

[42]  J. Seoane.  Escaping from the TGFβ anti-proliferative control , 2006 .

[43]  Jianmin Zhang,et al.  p16INK4a modulates p53 in primary human mammary epithelial cells. , 2006, Cancer research.

[44]  G. Peters,et al.  Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.

[45]  J. Seoane.  Escaping from the TGFbeta anti-proliferative control. , 2006, Carcinogenesis.

[46]  J. Egozcue,et al.  Telomere dysfunction drives chromosomal instability in human mammary epithelial cells , 2005, Genes, chromosomes & cancer.

[47]  J. Engelman,et al.  Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. , 2005, Cancer research.

[48]  S. Lakhani,et al.  Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis , 2005, Breast Cancer Research.

[49]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[50]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[51]  Daniel Birnbaum,et al.  Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. , 2005, Cancer research.

[52]  K. Chin,et al.  In situ analyses of genome instability in breast cancer , 2004, Nature Genetics.

[53]  J. Shay,et al.  Does a sentinel or a subset of short telomeres determine replicative senescence? , 2004, Molecular biology of the cell.

[54]  C. Perou,et al.  Cell-Type-Specific Responses to Chemotherapeutics in Breast Cancer , 2004, Cancer Research.

[55]  N. Sonenberg,et al.  Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. , 2004, Cancer cell.

[56]  L. Haupt,et al.  Loss of Chromosomal Integrity in Human Mammary Epithelial Cells Subsequent to Escape from Senescence , 2001, Journal of Mammary Gland Biology and Neoplasia.

[57]  B. Shpitz,et al.  Telomerase activity in ductal carcinoma in situ of the breast , 1999, Breast Cancer Research and Treatment.

[58]  Jan F. Silverman,et al.  Molecular Evolutionary Patterns in Breast Cancer , 2003, Advances in anatomic pathology.

[59]  F. Wyllie,et al.  A P53-dependent, telomere-independent proliferative life span barrier in human astrocytes consistent with the molecular genetics of glioma development. , 2003, Cancer research.

[60]  P. Yaswen,et al.  Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines , 2003, Oncogene.

[61]  Carlos L. Arteaga,et al.  Targeting the TGFβ signaling network in human neoplasia , 2003 .

[62]  P. Yaswen,et al.  Human epithelial cell immortalization as a step in carcinogenesis. , 2003, Cancer letters.

[63]  R. Salunga,et al.  Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Manel Esteller,et al.  Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. , 2003, Cancer research.

[65]  C. Arteaga,et al.  Targeting the TGF beta signaling network in human neoplasia. , 2003, Cancer cell.

[66]  Sophie Lelièvre,et al.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.

[67]  W. Hahn,et al.  A Two-Stage, p16INK4A- and p53-Dependent Keratinocyte Senescence Mechanism That Limits Replicative Potential Independent of Telomere Status , 2002, Molecular and Cellular Biology.

[68]  P. Yaswen,et al.  Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion , 2002, Oncogene.

[69]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[70]  L. Holmberg,et al.  Tumour markers in breast carcinoma correlate with grade rather than with invasiveness , 2001, British Journal of Cancer.

[71]  P. Yaswen,et al.  Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor β growth inhibition in p16INK4A(−) human mammary epithelial cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J. Shay,et al.  Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. , 2001, Genes & development.

[73]  J W Gray,et al.  The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. , 2001, Cancer research.

[74]  Thea D. Tlsty,et al.  Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes , 2001, Nature.

[75]  P. Yaswen,et al.  Immortal transformation and telomerase reactivation of human mammary epithelial cells in culture , 2001 .

[76]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[77]  Heidi S. Liss,et al.  Subsenescent Telomere Lengths in Fibroblasts Immortalized by Limiting Amounts of Telomerase* , 2000, The Journal of Biological Chemistry.

[78]  P. Yaswen,et al.  p57KIP2 expression and loss of heterozygosity during immortal conversion of cultured human mammary epithelial cells. , 1999, Cancer research.

[79]  K. Shroyer,et al.  Telomerase is a highly sensitive and specific molecular marker in fine-needle aspirates of breast lesions. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  P. Yaswen,et al.  Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells , 1999, Oncogene.

[81]  A. Brenner,et al.  Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation , 1998, Oncogene.

[82]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[83]  P. Yaswen,et al.  Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells. , 1997, Molecular biology of the cell.

[84]  Wenyi Wei,et al.  Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. , 1997, Science.

[85]  P. Yaswen,et al.  Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells , 1997, Molecular and cellular biology.

[86]  Bas van Steensel,et al.  Control of telomere length by the human telomeric protein TRF1 , 1997, Nature.

[87]  D. Johnston,et al.  Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[88]  O. Olopade,et al.  Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[89]  Z. Strezoska,et al.  Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[90]  Kazuhiro Yoshida,et al.  Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates , 1996, International journal of cancer.

[91]  M. Stanley,et al.  Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. , 1996, Oncogene.

[92]  J. Geradts,et al.  High frequency of aberrant p16(INK4A) expression in human breast cancer. , 1996, The American journal of pathology.

[93]  D. Wazer,et al.  Mutant p53-induced immortalization of primary human mammary epithelial cells. , 1996, Cancer research.

[94]  Galloway Da,et al.  HUMAN PAPILLOMAVIRUS TYPE 16 E7 ALLEVIATES A PROLIFERATION BLOCK IN EARLY PASSAGE HUMAN MAMMARY EPITHELIAL CELLS , 1996 .

[95]  L. Gollahon,et al.  Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). , 1996, Oncogene.

[96]  C. Greider,et al.  Developmental and tissue-specific regulation of mouse telomerase and telomere length. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[97]  M. Stampfer,et al.  Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand‐dependent transformed phenotype , 1995, Journal of cellular biochemistry.

[98]  L. Hengst,et al.  A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells , 1994, Molecular and cellular biology.

[99]  V. Band,et al.  Expression and stability of p53 protein in normal human mammary epithelial cells. , 1993, Carcinogenesis.

[100]  R. Metcalf,et al.  p53 mutations in human immortalized epithelial cell lines. , 1993, Carcinogenesis.

[101]  P. Yaswen,et al.  TGFβ induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects , 1993 .

[102]  R. Metcalf,et al.  Errata: p53 Mutations in human immortalized epithelial cell lines (Carcinogenesis (1993) 14 (833-839)) , 1993 .

[103]  M. Kraus,et al.  Oncogenic potential of erbB-2 in human mammary epithelial cells. , 1991, Oncogene.

[104]  S. Bates,et al.  Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. , 1989, Cancer research.

[105]  R. Dickson,et al.  Stimulation of epithelial membrane antigen expression by transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. , 1989, Cancer research.

[106]  E. Lane,et al.  Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. , 1989, Journal of cell science.

[107]  M. Stampfer,et al.  Chromosome analyses of human mammary epithelial cells at stages of chemical-induced transformation progression to immortality. , 1989, Cancer genetics and cytogenetics.

[108]  F. McCormick,et al.  Transformation of human mammary epithelial cells by oncogenic retroviruses. , 1988, Cancer research.

[109]  M. Stampfer,et al.  Human mammary epithelial cells in culture: differentiation and transformation. , 1988, Cancer treatment and research.

[110]  M. Stampfer,et al.  Factors influencing benzo[a]pyrene metabolism in human mammary epithelial cells in culture. , 1985, Carcinogenesis.

[111]  Martha R. Stampfer,et al.  Isolation and growth of human mammary epithelial cells , 1985 .

[112]  M. Stampfer,et al.  Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[113]  S. L. Hammond,et al.  Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[114]  J. Bartholomew,et al.  Metabolism of Benzo(a)pyrene by Human Epithelial and Fibroblastic Cells: Metabolite Patterns and DNA Adduct Formation , 1982, Journal of cellular biochemistry.